Quadrant Capital Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,210
| Closed | -$42.8K | – | 1513 |
|
|
2026
Q1 | $42.8K | Buy |
1,210
+975
| +415% | +$39.7K | ﹤0.01% | 1755 |
|
|
2025
Q4 | $9.54K | Buy |
235
+168
| +251% | +$7.31K | ﹤0.01% | 2218 |
|
|
2025
Q3 | $3.15K | Buy |
+67
| New | +$3.47K | ﹤0.01% | 2404 |
|
|
2025
Q2 | – | Sell |
-7,336
| Closed | -$443K | – | 1605 |
|
|
2025
Q1 | $443K | Buy |
7,336
+7,047
| +2,438% | +$454K | 0.02% | 820 |
|
|
2024
Q4 | $19.8K | Sell |
289
-275
| -49% | -$19.2K | ﹤0.01% | 1896 |
|
|
2024
Q3 | $40.6K | Sell |
564
-549
| -49% | -$38.7K | ﹤0.01% | 1551 |
|
|
2024
Q2 | $77.2K | Buy |
1,113
+348
| +45% | +$25.4K | 0.01% | 1166 |
|
|
2024
Q1 | $61.3K | Sell |
765
-866
| -53% | -$77.2K | ﹤0.01% | 1275 |
|
|
2023
Q4 | $179K | Buy |
1,631
+500
| +44% | +$51.7K | 0.02% | 654 |
|
|
2023
Q3 | $114K | Sell |
1,131
-227
| -17% | -$26.1K | 0.01% | 798 |
|
|
2023
Q2 | $185K | Buy |
1,358
+196
| +17% | +$23.9K | 0.02% | 560 |
|
|
2023
Q1 | $121K | Buy |
1,162
+138
| +13% | +$13.3K | 0.01% | 733 |
|
|
2022
Q4 | $90.8K | Buy |
1,024
+287
| +39% | +$23.8K | 0.01% | 837 |
|
|
2022
Q3 | $59K | Buy |
737
+614
| +499% | +$57.9K | 0.01% | 946 |
|
|
2022
Q2 | $12K | Sell |
123
-7
| -5% | -$840 | ﹤0.01% | 1549 |
|
|
2022
Q1 | $20K | Buy |
130
+64
| +97% | +$8.94K | ﹤0.01% | 1321 |
|
|
2021
Q4 | $9K | Sell |
66
-7
| -10% | -$991 | ﹤0.01% | 1661 |
|
|
2021
Q3 | $10K | Buy |
73
+35
| +92% | +$4.58K | ﹤0.01% | 1575 |
|
|
2021
Q2 | $5K | Hold |
38
| – | – | ﹤0.01% | 1824 |
|
|
2021
Q1 | $5K | Hold |
38
| – | – | ﹤0.01% | 1768 |
|
|
2020
Q4 | $4K | Buy |
38
+13
| +52% | +$1.23K | ﹤0.01% | 1737 |
|
|
2020
Q3 | $2K | Hold |
25
| – | – | ﹤0.01% | 1796 |
|
|
2020
Q2 | $2K | Sell |
25
-5
| -17% | -$348 | ﹤0.01% | 1888 |
|
|
2020
Q1 | $1K | Sell |
30
-45
| -60% | -$4.15K | ﹤0.01% | 1964 |
|
|
2019
Q4 | $7K | Buy |
75
+50
| +200% | +$5.33K | ﹤0.01% | 1991 |
|
|
2019
Q3 | $2K | Hold |
25
| – | – | ﹤0.01% | 2075 |
|
|
2019
Q2 | $2K | Sell |
25
-722
| -97% | -$59.4K | ﹤0.01% | 2114 |
|
|
2019
Q1 | $61K | Buy |
747
+722
| +2,888% | +$52.5K | 0.01% | 1090 |
|
|
2018
Q4 | $1K | Hold |
25
| – | – | ﹤0.01% | 2026 |
|
|
2018
Q3 | $1K | Hold |
25
| – | – | ﹤0.01% | 1988 |
|
|
2018
Q2 | $1K | Hold |
25
| – | – | ﹤0.01% | 1995 |
|
|
2018
Q1 | $1K | Hold |
25
| – | – | ﹤0.01% | 1978 |
|
|
2017
Q4 | $1K | Hold |
25
| – | – | ﹤0.01% | 1926 |
|
|
2017
Q3 | $1K | Hold |
25
| – | – | ﹤0.01% | 1937 |
|
|
2017
Q2 | $1K | Hold |
25
| – | – | ﹤0.01% | 1709 |
|
|
2017
Q1 | $1K | Hold |
25
| – | – | ﹤0.01% | 1768 |
|
|
2016
Q4 | $1K | Buy |
+25
| New | +$1.06K | ﹤0.01% | 1658 |
|
Other funds holding CNMD
ICM
Quadrant Capital Group's CNMD Position: Q2 2026 in Review
Quadrant Capital Group sold out of CONMED (CNMD) in Q2 2026, closing a stake of 1,210 shares — an estimated $42.8K sold.
Quadrant Capital Group first reported a position in CNMD in Q4 2016 and held it in 37 quarters. The position peaked at $443K in Q1 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Quadrant Capital Group reported no remaining CONMED position as of Q2 2026 after selling out during the quarter.
- Quadrant Capital Group sold 1,210 CONMED shares in Q2 2026, an estimated $42.8K.
- Quadrant Capital Group first reported a position in CONMED in Q4 2016 and held it in 37 quarters.
- Quadrant Capital Group's CONMED position peaked at $443K in Q1 2025.
- 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.